ObesityNCT05362747
ProduceRx: Improving Weight and Cardiovascular Risk in Adults With Food Insecurity and Obesity
A study testing Behavioral weight loss and produce vouchers in people with Obesity, run by University of Pennsylvania at 1 site in United States.
Trial summary
This is a pilot randomized controlled trial to assess the effects of providing produce vouchers during behavioral weight loss treatment in 40 adults with obesity and food insecurity. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Obesity
- What is being tested?
- Behavioral weight loss and produce vouchers
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 31 participants
- Where
- 1 siteUnited States
- Study dates
- 26 Apr 2022to 2 Jun 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age ≥ 18 years old
- BMI ≥ 30 kg/m2
- Food insecurity as assessed by the two-item "hunger vital sign"
- Subjects must:
- have reliable telephone or Internet service to communicate with study staff
- plan to remain in the Philadelphia area for the next 6 months or more
- Understand and be willing to comply with all study-related procedures and agree to participate in the study by giving written informed consent.
Who cannot join
- Pregnant, nursing, or plans to become pregnant in the next 6 months
- Serious medical risk such as uncontrolled diabetes, cancer, congestive heart failure, or recent cardiac event (e.g., myocardial infarction or stroke within the past 6 months)
- Clinically significant hepatic or renal disease
- History of (or plans for) bariatric surgery
- Current psychiatric disorder that significantly interferes with daily living
- Self-reported alcohol or substance abuse within the past 12 months
Show all 14Show fewer
- Use in past 3 months of medications known to induce significant weight loss (i.e., prescription weight loss medications) or weight gain (e.g., chronic use of oral steroids, second generation antipsychotics)
- Loss of ≥ 10 lb of body weight within the past 3 months
- Participation in a structured weight loss program in the prior 6 months
- Inability to walk 2 blocks comfortably or engage in some other form of aerobic activity (e.g., swimming)
- Participant from same household
- Inability to attend treatment and/or assessment visits
- Lack of capacity to provide informed consent
- Any serious or unstable medical or psychological condition that, in the opinion of the investigator, would compromise the patient's safety or successful participation in the study
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
About this study
This is a pilot randomized controlled trial to assess the effects of providing produce vouchers during behavioral weight loss treatment in 40 adults with obesity and food insecurity. Participants will be randomized to ProduceRx (12 weekly sessions of in-person, behavioral weight loss counseling (BWL) + produce prescriptions) or a waitlist control (WLC).
Read the detailed description
The proposed investigation is a single-site, pilot RCT to assess the effect of BWL and produce vouchers (ProduceRx) on diet quality, weight loss and cardiovascular risk factors among adult participants with food insecurity and obesity. Adults (N=40) will be randomized to a 12-week program that provides weekly, 30-minute BWL sessions + produce vouchers (n=20) or WLC (n=20). Outcomes will be assessed at baseline and at 12 weeks and include questionnaires, and measurements of weight, height, and cardiometabolic risk factors (blood pressure, waist circumference, and pulse). Participants will also be asked to complete two 24-hour dietary recalls.
- Conditions
- Obesity
- Being tested
- Behavioral weight loss and produce vouchers
- Keywords
- food insecurity
- Medical subject headings
- Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Behavioral weight loss and produce vouchersBehavioural
Participants will receive weekly 30-minute, individual, in-person lifestyle counseling delivered by trained interventionists (e.g., registered dietitians) that consists of behavioral, dietary, and physical activity counseling. ProduceRx vouchers will be in the form of Food Bucks and will be provided at each session.
| Study group | Role | What they receive |
|---|---|---|
| ProduceRx | Experimental | Participants in the ProduceRx intervention group will be provided with BWL and produce vouchers for fresh fruits and vegetables. Receives: Behavioral: Behavioral weight loss and produce vouchers |
| Waitlist Control | No intervention | Participants in the WLC group with be asked to stay weight stable, not to make changes in their eating and physical activity behaviors, and not to seek treatment for weight or eating during the waiting period. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dietary quality
Change from baseline to 12 weeks in dietary quality from 24-hour dietary recalls summarized into Healthy Eating Index (HEI) Scores and caloric intake. Scores range from 0 to 100 with higher scores indicating better diet quality.
Measured: Baseline, 12 weeks
Secondary outcomes (16)
Percent initial weight loss
Change from baseline to 12 weeks in percent initial weight loss
Measured: Baseline, 12 weeks
Systolic blood pressure
Change from baseline to 12 weeks in systolic blood pressure
Measured: Baseline, 12 weeks
Diastolic blood pressure
Change from baseline to 12 weeks in diastolic blood pressure
Measured: Baseline, 12 weeks
Waist circumference
Change from baseline to 12 weeks in waist circumference
Measured: Baseline, 12 weeks
Pulse
Change from baseline to 12 weeks in pulse rate
Measured: Baseline, 12 weeks
Health-related quality of life
Change from baseline to 12 weeks in general health-related quality of life (Short-Form-36). Scores range from 0 to 100 with higher scores indicating better quality of life.
Measured: Baseline, 12 weeks
Weight-related quality of life
Change from baseline to 12 weeks in weight-related QOL (Impact of Weight on Quality of Life-Lite). Scores range from 0 to 100 with higher scores indicating better quality of life.
Measured: Baseline, 12 weeks
Food security
Change from baseline to 12 weeks in the USDA Food Security Survey. Scores range from 0-10 with higher scores indicating lower food security.
Measured: Baseline, 12 weeks
Depressive symptoms
Change from baseline to 12 weeks in Patient Health Questionnaire-8 Scores. Scores range from 0 to 24 with higher scores indicating more depressive symptoms.
Measured: Baseline, 12 weeks
Food addiction
Change from baseline to 12 weeks in Yale Food Addiction Scores. Symptom scores range from 0 to 11 with higher scores indicating more symptoms.
Measured: Baseline, 12 weeks
Eating behaviors
Change from baseline to 12 weeks in Eating Behaviors. Higher scores indicate greater agreement.
Measured: Baseline, 12 weeks
Self-regulation of eating
Change from baseline to 12 weeks in self-regulation of eating as measured by the Regulation of Eating Behavior Scale. Scores range from 24 to 168 with higher scores indicating more self-regulation.
Measured: Baseline, 12 weeks
Self-regulation of exercise
Change from baseline to 12 weeks in Behavioral Regulation in Exercise Questionnaire. Scores range from 0 to 76 with higher scores indicating more self-regulation.
Measured: Baseline, 12 weeks
Self-efficacy
Change from baseline to 12 weeks in scores on the Weight Efficacy Lifestyle Questionnaire. Total scores range from 0 to 180. Higher scores represent greater eating self-efficacy.
Measured: Baseline, 12 weeks
Physical activity
Change from baseline to 12 weeks in scores on the International Physical Activity Questionnaire. Higher scores indicate more physical activity.
Measured: Baseline, 12 weeks
Perceived Stress Scale
Change from baseline to 12 weeks in scores on the Perceived Stress Scale. Scores range from 0-56 with higher scores indicating more stress.
Measured: Baseline, 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 May 2022
- Study start26 Apr 2022
- Primary completion2 Jun 2023
- Study completion2 Jun 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ObesityStudies of the same condition, open and under way.
- More trials run by University of PennsylvaniaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Pennsylvania
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Ariana M Chao, PhD, CRNP, Principal investigator, University of Pennsylvania
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05362747
- Sponsor's protocol ID
- 851009
- Status last verified
- Jul 2023
- First submitted
- 26 Apr 2022
- Last updated
- 12 Jul 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Jul 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- ProduceRx: Improving Weight and Cardiovascular Risk in Adults With Food Insecurity and Obesity
- ClinicalTrials.gov ID
- NCT05362747
- Acronym / sponsor ID
- 851009
- Conditions
- Obesity
- Keywords
- food insecurity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- University of PennsylvaniaUniversity, hospital or other
- Study start
- 26 Apr 2022 (actual)
- Primary completion
- 2 Jun 2023 (actual)
- Study completion
- 2 Jun 2023 (actual)
- First posted
- 5 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a pilot randomized controlled trial to assess the effects of providing produce vouchers during behavioral weight loss treatment in 40 adults with obesity and food insecurity. Participants will be randomized to ProduceRx (12 weekly sessions of in-person, behavioral weight loss counseling (BWL) + produce prescriptions) or a waitlist control (WLC).
Detailed description
The proposed investigation is a single-site, pilot RCT to assess the effect of BWL and produce vouchers (ProduceRx) on diet quality, weight loss and cardiovascular risk factors among adult participants with food insecurity and obesity. Adults (N=40) will be randomized to a 12-week program that provides weekly, 30-minute BWL sessions + produce vouchers (n=20) or WLC (n=20). Outcomes will be assessed at baseline and at 12 weeks and include questionnaires, and measurements of weight, height, and cardiometabolic risk factors (blood pressure, waist circumference, and pulse). Participants will also be asked to complete two 24-hour dietary recalls.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| ProduceRx | Experimental | Behavioral: Behavioral weight loss and produce vouchersParticipants in the ProduceRx intervention group will be provided with BWL and produce vouchers for fresh fruits and vegetables. |
| Waitlist Control | No intervention | –Participants in the WLC group with be asked to stay weight stable, not to make changes in their eating and physical activity behaviors, and not to seek treatment for weight or eating during the waiting period. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Age ≥ 18 years old
- BMI ≥ 30 kg/m2
- Food insecurity as assessed by the two-item "hunger vital sign"
- Subjects must:
- Understand and be willing to comply with all study-related procedures and agree to participate in the study by giving written informed consent.
Key exclusion criteria (14 listed)
- Pregnant, nursing, or plans to become pregnant in the next 6 months
- Serious medical risk such as uncontrolled diabetes, cancer, congestive heart failure, or recent cardiac event (e.g., myocardial infarction or stroke within the past 6 months)
- Clinically significant hepatic or renal disease
- History of (or plans for) bariatric surgery
- Current psychiatric disorder that significantly interferes with daily living
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Behavioral weight loss and produce vouchersParticipants will receive weekly 30-minute, individual, in-person lifestyle counseling delivered by trained interventionists (e.g., registered dietitians) that consists of behavioral, dietary, and physical activity counseling. ProduceRx vouchers will be in the form of Food Bucks and will be provided at each session. | Behavioural | ProduceRx |
Primary outcome
Dietary quality
Time frame: Baseline, 12 weeks
Change from baseline to 12 weeks in dietary quality from 24-hour dietary recalls summarized into Healthy Eating Index (HEI) Scores and caloric intake. Scores range from 0 to 100 with higher scores indicating better diet quality.
16 secondary outcomes
Percent initial weight loss
Time frame: Baseline, 12 weeks
Systolic blood pressure
Time frame: Baseline, 12 weeks
Diastolic blood pressure
Time frame: Baseline, 12 weeks
Waist circumference
Time frame: Baseline, 12 weeks
Pulse
Time frame: Baseline, 12 weeks
Health-related quality of life
Time frame: Baseline, 12 weeks
Weight-related quality of life
Time frame: Baseline, 12 weeks
Food security
Time frame: Baseline, 12 weeks
Depressive symptoms
Time frame: Baseline, 12 weeks
Food addiction
Time frame: Baseline, 12 weeks
Eating behaviors
Time frame: Baseline, 12 weeks
Self-regulation of eating
Time frame: Baseline, 12 weeks
Self-regulation of exercise
Time frame: Baseline, 12 weeks
Self-efficacy
Time frame: Baseline, 12 weeks
Physical activity
Time frame: Baseline, 12 weeks
Perceived Stress Scale
Time frame: Baseline, 12 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jul 2023.
- Individual participant dataSharing planned: No
Related trials for Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ariana M Chao, PhD, CRNP principal investigator
University of Pennsylvania
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Behavioral weight loss and produce vouchers in people with Obesity, run by University of Pennsylvania at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dietary quality (time frame: Baseline, 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jul 2023.